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Abstract
Retinoids, vitamin A derivatives, are important regulators of the growth and differentiation of skin cells. Although
retinoids are therapeutically used for several skin ailments, little is known about their effects on P2 receptors, known to be
involved in various functions in the skin. DNA array analysis showed that treatment of normal human epidermal
keratinocytes (NHEKs) with all-trans-retinoic acid (ATRA), an agonist to RAR (retinoic acid receptor), enhanced the
expression of mRNA for the P2Y2 receptor, a metabotropic P2 receptor that is known to be involved in the proliferation
of the epidermis. The expression of other P2 receptors in NHEKs was not affected by ATRA. ATRA increased the mRNA
for the P2Y2 receptor in a concentration-dependent fashion (1 nM to 1 mM). Am80, a synthesized agonist to RAR,
showed a similar enhancement, whereas 9-cis-retinoic acid (9-cisRA), an agonist to RXR (retinoid X receptor), enhanced
P2Y2 gene expression to a lesser extent. Ca
2+ imaging analysis showed that ATRA also increased the function of P2Y2
receptors in NHEKs. Retinoids are known to enhance the turnover of the epidermis by increasing both proliferation and
terminal differentiation. The DNA microarray analysis also revealed that ATRA upregulates various genes involved in the
differentiation of NHEKs. Our present results suggest that retinoids, at least in part, exert their proliferative effects by
upregulating P2Y2 receptors in NHEKs. This effect of retinoids may be closely related to their therapeutic effect against
various ailments or aging events in skins such as over-keratinization, pigmentation and re-modeling.
Abbreviations: ATRA –all-trans retinoic acid; [Ca
2+]i–intracellular calcium concentration; 9-cisRA – 9-cis retinoic acid;
InsP3–inositol 1,4,5-trisphosphate; 2MeSADP–2-methyl-thio-ADP; NHEKs–normal human epidermal kratinocytes;
RAR–retinoic acid receptor; RXR–retinoid X receptor; UTP–uridine 50-triphosphate
Introduction
The epidermis, the outermost part of the skin tissue, is a
stratiﬁed squamous epithelium composed principally of
keratinocytes with a highly dynamic structure [1]. Basal
keratinocytes are located immediately above the basement
membrane that separates the epidermal and dermal com-
partments. The basal layer is a proliferative layer from
which keratinocytes withdraw from the cell cycle and
commit to terminal differentiation. Differentiating cells
migrate to the skin surface, going through suprabasal layers
known as the spinous and granular layers. At the skin
surface, dead and terminally-differentiated keratinocytes
compose the stratum corneum, the so-called skin barrier.
The skin covers most of the body and is exposed to mul-
tiple external stimuli such as dryness, chemicals, noxious
heat, and UV light.
Endogenous chemical transmitters such as ATP, brady-
kinin, and histamine modulate skin physiology under
normal conditions, after skin injury, and during inﬂam-
matory diseases and allergic reactions. Epidermal cells
change the intracellular Ca
2+ concentration ([Ca
2+]i) in
response to various environmental stimuli [2Y5]. The
change in [Ca
2+]i is an essential factor for the homeosta-
sis of the skin epidermis and the regulation of the growth
of epidermal keratinocytes [6Y8]. Because of exposure to
such stimuli, the skin causes an aberrant change in [Ca
2+]i
and often suffers aging damages such as over-keratiniza-
tion, pigmentation and re-modeling (e.g., formation of
wrinkles).
Vitamin A is known as one of the vital nutrients for the
body. Retinyl esters and b-carotene from diet are converted
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circulation. They are then metabolized to retinoic acid
(RA), a biologically active metabolite of retinoids [9].
Retinoids have been used clinically to prevent aging events
or other disorders in the skin. RA works through gene
activation as a ligand of the nuclear receptors for ret-
inoic acid (RARa, b and g), and the retinoid X recep-
tors (RXRa, b and g)[ 10, 11]. RARs bind all-trans-RA
(ATRA), whereas RXRs interact exclusively with 9-cisRA
stereo-isomers. Retinoid signals are believed to be trans-
duced by RARYRXR heterodimers [11], but RXRs have
also been shown to be heterodimeric partners of a num-
ber of other members of the nuclear receptor superfamily
(e.g., vitamin D receptors and peroxisome proliferators)
[12]. The epidermis expresses RXRa,R X R b,R A R a
and RARg.R X R a and RARg are dominant in their
expression [9]. Although retinoids acting on these nuclear
receptors regulate both epidermal proliferation and dif-
ferentiation [13Y15], little is known about the molecular
cascades linking the retinoid receptors to cell growth/
differentiation.
Adenosine 50-triphosphate (ATP) is now recognized as
an important extracellular molecule that mediates cell-to-
cell communication via ATP receptors, P2 receptors. P2
receptors are classiﬁed into two subfamilies; the ligand-
gated channel P2X receptors (P2X1-7) and the G protein-
coupled P2Y receptors (P2Y1,2,4,6,11-14). P2 receptors
are distributed in almost all tissues in the body including
the skin. Exogenously applied ATP causes an increase in
[Ca
2+]i in human epidermal keratinocytes [2]. Cultured
human keratinocytes can release ATP in response to me-
chanical stimulation [16] or even spontaneously [3]. Skin
cells express P2 receptors, especially P2X5, P2X7, P2Y1
and P2Y2 receptors, each of which is expressed in a
spatially distinct zone of the epidermis and has distinct
functions in epidermal cell growth and/or differentiation
[17]. Recently, we have reported that mechanical stimula-
tion of single normal human epidermal keratinocytes
(NHEKs) produces a propagating Ca
2+ wave that is medi-
ated by extracellular ATP and the activation of P2Y2 re-
ceptors [16]. The P2Y2 receptor has been found to be a
critical molecule that regulates the proliferation of the
basal layer of the epidermis [17]. These ﬁndings suggest
that intracellular signals mediated by P2Y2 receptors are
closely involved in various epidermal functions. We hy-
pothesize that regulation of P2Y2 receptor-mediated signals
could lead to therapeutic effects against several ailments or
aging events in skin such as over-keratinization, pigmenta-
tion and re-modeling.
In the present study, we report that the treatment of cells
with retinoids selectively upregulated the mRNA and
function of P2Y2 receptors in NHEKs. We also dem-
onstrate that the upregulation is mainly mediated by
RAR, presumably RARa. The RARa agonist ATRA mim-
ics an increases in P2Y2 receptors without increasing
other P2 receptors in NHEKs. Our present ﬁndings sug-
gest that retinoids might at least in part exert their thera-




All-trans retinoic acid (ATRA), 9-cis retinoic acid (9-
cisRA) and uridine 50-triphosphate (UTP) were purchased
from Sigma Chemical Co. (St. Louis, MO). Am80 was
a kind gift from Prof. Kagechika (Tokyo Univ.) [18].
Retinoids and Am80 were dissolved in ethanol and stored
at j30 -C.
Cells and cell culture
Normal human epidermal keratinocytes (NHEKs) were
obtained as cyropreserved ﬁrst-passage cells from neonatal
foreskins (Kurabo, Osaka, Japan). Cells were cultured in
serum-free keratinocyte growth medium, Humedia-KB2
(Kurabo, Osaka, Japan) supplemented with bovine pituitary
extract (0.4% v/v), human recombinant epidermal growth
factor (0.1 ng/ml), insulin (10 mg/ml), hydrocortisone
(0.5 mg/ml), gentamicin (50 mg/ml) and amphotericin-B
(50 ng/ml). The medium was replaced every 2Y3 days. In
the case of retinoid treatment, the normal culture medium
was replaced with the non-supplemented Humedia-KB2
about 24 h before the retinoid treatment in order to remove
possible effects from the medium. For Ca
2+ imaging exper-
iments, cells were plated on collagen-coated coverslips.
Total RNA preparation
NHEKs were prepared in collagen-coated 60 mm dishes
(1.5   10
5 cells/dish). After washing the cells twice with
PBS, total RNA was prepared with an RNeasy Mini total
RNA Preparation Kit (Qiagen GmbH, Hilden, Germany)
according to the manufacturer’s instructions.
Quantitative RT-PCR of P2 receptors
RT-PCRampliﬁcationswere performedusingTaqman One-
step RT-PCR Master Mix Reagents, and 200 nM of each P2
receptor speciﬁc primer and 100 nM of Taqman probe.
Using Primer Express computer software, (Applied Bio-
systems Japan Ltd., Tokyo, Japan), clone-speciﬁc primers
were designed to recognize human P2Y1 (Taqman Probe,
50-tcagaccccagcaatgtgtgctttca-30;forward,50-gagggcccggctt-
gatt-30;reverse,50-atacgtggcataaaccctgtca-30), P2Y2 (Taqman
probe, 50-aacctttactgcagcatcctcttcctcacc-30;f o r w a r d ,5 0-
tggtgcgcttcctcttctaca-30;r e v e r s e ,5 0-accggtgca-cgctgatg-30),
and P2Y11 (Taqman probe, 50-cgacgacaaactcagtgggttccagg-
30; forward, 50-ctgccctgccaacttcttg-30;r e v e r s e ,5 0-accag-
tatgggccacaggaa-30) receptors mRNA sequences. All pri-
mers had similar melting temperatures for running the same
cycling program for all samples. RT-PCR was done by 30
min reverse transcription at 48 -C, 10 min AmpliTaq Gold
activation at 95 -C, then 15 s denaturation at 95 -C, 1 min
annealing and elongation at 60 -C for 40 cycles in a
PRISM7700 (Applied Biosystems Japan Ltd). To exclude
492 K. Fujishita et al.the contamination of unspeciﬁc PCR products such as
primer dimmers, melting curve analysis was applied to all
ﬁnal PCR products after the cycling protocol. Primers for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Ap-
plied Biosystems Japan Ltd) was used for normalization.
DNA micro-array analysis
Converting total RNA to the targets for Affymetrix
GeneChip DNA microarray hybridization was done ac-
cording to the manufacturer’s instructions. The targets were
hybridized to human genome U95A GeneChip DNA micro-
array (Affymetrix, Santa Clara, CA, USA) for 16Y24 h at
45 -C. After the hybridization, the DNA microarrays were
washed and stained on Fluidics Station (Affymetrix) ac-
cording to the protocol provided by Affymetrix. Then, the
DNA microarrays were scanned, and the images obtained
were analyzed by Microarray Suite Expression Analysis
Software (version 4.0; Affymetrix). The DNA microarray
analysis data was obtained from six independent samples
(n = 6).
Ca
2+ imaging in single NHEKs
NHEKs were cultured in collagen-coated glass coverslips
at density of 1   10
5 cells/ml. Changes in the intracellular
calcium concentration ([Ca
2+]i) in single cells were mea-
sured by the fura-2 method as described by Grynkiewicz
et al. [19] with minor modiﬁcations [20]. In brief, the
culture medium of cells grown on a coverslip was replaced
with balanced salt solution (BSS) of the following com-
position (mM): NaCl 150, KCl 5.0, CaCl2 1.8, MgCl2 1.2,
N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid
(HEPES) 25, and D-glucose 10 (pH = 7.4). The cells were
loaded with 5 mM fura-2 acetoxymethylester (fura-2 AM)
(Molecular Probes Inc., Eugene) at room temperature
(20Y22 -C) in BSS for 45 min, followed by BSS and a
further 15 min incubation to allow de-esteriﬁcation of the
loaded dye. The coverslips were mounted on an inverted
epiﬂuorescence microscope (TE-2000-U, Nikon, Tokyo,
Japan). Fluorescent images were obtained by alternate ex-
citation at 340 (F340) and 380 (F380) nm. The emission
signal at 510 nm was collected by a charge-coupled device
camera(C-6790,HamamatsuPhotonics,Hamamatsu,Japan)
coupled with an image intensiﬁer (GaAsP, C8600-03,
Hamamatsu Photonics), and digitized signals were stored
and processed using an image processing system (Aqua-
cosmos, Hamamatsu Photonics, Hamamatsu, Japan). Drugs
were dissolved in BSS and applied by superfusion.
Detection of ATP release
NHEKs were prepared in collagen-coated 22   40 mm
chamber glasses at a density of 1   10
5 cells/ml. After
superfusion with BSS for 5 min, the cell chamber was
ﬁlled with a luciferinYluciferase reagent (ATP biolumines-
cence assay kit CLS, Roche Diagnostics GmbH, Mann-
heim, Germany). ATP bioluminescence was detected and
visualized with a VIM camera (C2400-35, Hamamatsu
Photonics, Hamamatsu, Japan) using an integration time of
10 s. The absolute ATP concentration was estimated by
using standard ATP solution (Roche Diagnostics GmbH).
Data were imaged with Aquacosmos software (Hamamatsu
Photonics) and analyzed with NIH-image 1.61 software
(Apple computer, Inc., USA). For mechanical stimulation,
a single NHEK in the center of the microscopic ﬁeld was
probed with a glass micropipette using a micromanipulator
(Narishige, Tokyo, Japan). Under visible light, the tip of
the micropipette was positioned approx. 2 mm over the cell
to be stimulated. When sampling, the micropipette was
rapidly lowered by approx. 2 mm and then rapidly returned
to its original position. If the stimulated cell showed any
sign of damage (abnormal morphology), the experiment
was eliminated.
Statistics
Experimental results are expressed as mean T SEM
Statistical differences between two groups were determined
by Student’s t-test (including the DNA microarray experi-
ments). The multiple linear regression was used to analyze
the effect of various concentrations of retinoids on P2Y2
receptor expression. The percentage of the P2Y2 receptor
mRNA expression was chosen as outcome variable, and
the exposure time of retinoids at each concentration was
dummy coded and used as predictor variables.
Results
Retinoids upregulate mRNAs for P2Y2 receptors in NHEKs
The skin expresses multiple P2 receptors. We previously
showed that the expression of P2Y1, P2Y2 and P2Y11 is
relatively higher in NHEKs [16]. Firstly, we examined the
changes in the mRNAs for the P2 receptors induced by
retinoids in NHEKs using DNA array analysis. Unfortu-
nately, the DNA microarray we used (U95A GeneChip
DNA microarray) does not contain all cloned P2 receptor
genes (for example, P2Y11 receptors) but it contains P2Y1,
P2Y2, P2Y6, P2X1, P2X3, P2X4, P2X5 and P2X7 receptor
genes. Treatment of NHEKs with 0.1 mM all-trans retinoic
acid (ATRA) for 6 h caused a drastic increase in the
mRNA for P2Y2 receptor (304.1 T 38.1% of control,
n = 3). Interestingly, ATRA did not affect the expression of
any other P2 receptors included in U95A GeneChip
(Table 1), suggesting that ATRA selectively upregulates
P2Y2 receptors in NHEKs. This result was conﬁrmed
quantitatively using real-time RT-PCR (Figure 1). Treat-
ment of NHEKs with ATRA induced a similar increase in
the mRNA for P2Y2 receptors (264.4 T 59.1% of control,
n = 3) but not for other P2 receptors such as P2Y1 and
P2Y11 (P2Y1, 67.5 T 6.67, n = 3; P2Y11, 70.0 T 11.7% of
control, n = 3).
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dependency of changes in the mRNA expression for P2Y2
receptors induced by ATRA, its stereo-isomer 9-cis
retinoic acid (9-cisRA) and the synthetic RAR agonist
Am80. All these retinoids tested caused signiﬁcant and
drastic increases in the mRNA expression in a concentra-
tion- and incubation time-dependent manner (Figure 2).
After treatment with 1 mM ATRA and Am80 for 24 h, the
expression level reached to 768.4 T 458.1 and 862.2 T
24.7% of control, respectively (Figure 2A, B). 9-cisRA, an
agonist to RXRs and possibly to RARs, showed a moderate
but signiﬁcant rise in P2Y2 receptor mRNA in NHEKs
(Figure 2C). These results suggest that the upregulation of
P2Y2 receptors by retinoids would be mainly mediated by
RARs in NHEKs.
Enhancement by ATRA of the UTP-evoked increase in
[Ca
2+]i in NHEKs
We next investigated whether ATRA increases the function
of P2Y receptors in NHEKs. Activation of phospholipase C
(PLC)-linked P2Y2 receptors in NHEKs results in an
increase in [Ca
2+]i via inositol-1,4,5-trisphosphate (InsP3)-
mediated Ca
2+ release from stores [21]. We therefore
investigated the effect of ATRA on the increase in [Ca
2+]i
evoked by UTP, an agonist to P2Y2 receptors, in NHEKs.
The cells were stimulated with 0.1 mM ATRA or Am80 for
6 h, and then were incubated with normal culture medium
for an additional 18 h. UTP (100 mM) produced an increases
in [Ca
2+]i in NHEKs that were signiﬁcantly enhanced by
the ATRA- and Am80-treatment (133.2 T 4.1 and 127.8 T
6.3% of control, respectively (Figure 3B)). Similar en-
hancement of Ca
2+ responses to UTP in retinoids-treated
and -untreated cells was observed even in the absence of
extracellular Ca
2+ (Figure 3A). These results suggest that
ATRA and Am80 upregulates functional P2Y2 receptor in
NHEKs without changing the nature of Ca
2+ signals.
ATRA decreases spontaneous ATP release from NHEKs
NHEKs release ATP in response to mechanical stimulation
[16] or even spontaneously [3]. Endogenously released
ATP and activation of P2Y2 receptors form propagating
Ca
2+ waves in NHEKs [16]. We thus investigated whether
ATRA affects the release of ATP from NHEKs. Similarly
as in Figure 3, the cells were treated with 0.1 mM ATRA
for 6 h, and then incubated for another 18 h with normal
culture medium. The cells were bathed in solution contain-
ing luciferinYluciferase reagent and photons were counted
every 10 s prior to and after mechanical stimulation of the
NHEKs in a dark box. The left panels in Figure 4Aa &
a0 show phase contrast images of microscopic ﬁelds, and
the remaining panels (bYe&b 0Ye0) in Figure 4A show
bioluminescence images 10 s before (b & b0) and 10 (c &
c0), 20 (d & d0), 30 s (e & e0) after mechanical stimulation
in the same ﬁeld. ATP was released and diffused from the
stimulated site in both cultures. We found that the release
of ATP peaked around 10 s after mechanical stimulation,
and then gradually decreased to the pre-stimulated level in
60 s. The release of ATP at 10 s after mechanical stim-
ulation in ATRA-treated cells is higher than that in control
cells (Figure 4A c vs. c0). The photons derived from ATP
with and without mechanical stimulation were accumulated
for 60 s in both ATRA-treated and -untreated cells and
Table 1. ATRA-induced changes in expression pattern of P2 receptors in NHEKs.
Gene title Abbreviations Percentage of control (%) Statistics
Purinergic receptor P2X, ligand-gated ion channel, 1 P2RX1 94.9 T 8.5
Purinergic receptor P2X-like 1, orphan receptor P2RXL1 28.2 T 40.1
Purinergic receptor P2X, ligand-gated ion channel, 3 P2RX3 138.9 T 36.7
Purinergic receptor P2X, ligand-gated ion channel, 4 P2RX4 88.9 T 23.4
Purinergic receptor P2X, ligand-gated ion channel, 5 P2RX5 184.5 T 41.7
Purinergic receptor P2X, ligand-gated ion channel, 7 P2RX7 78.1 T 17.4
Purinergic receptor P2Y, G-protein coupled, 1 P2RY1 58.6 T 18.7
Purinergic receptor P2Y, G-protein coupled, 2 P2RY2 304.1 T 38.1 **
Pyrimidinergic receptor P2Y, G-protein coupled, 6 P2RY6 76.4 T 9.7
Cells were incubated with 0.1 mM ATRA for 6 h. The expression levels of each gene are shown as the average of triplicate microarray measurements.
Asterisks show signiﬁcant difference from control groups (**P G 0.01). Data were normalized by the signals in control (0.5% ethanol).
Figure 1. Changes in mRNA expression for P2Y receptors induced by
ATRA in NHEKs. Diagram shows the percentage of the quantity after
ampliﬁcation by real-time RT-PCR for P2Y1, P2Y2 and P2Y11 receptor
mRNAs extracted from NHEKs treated with 1 mM ATRA for 2 h.
Asterisks show signiﬁcant difference from control groups (white columns,
**P G 0.01). mRNAs of P2Y2 receptors were increased by more than two-
fold vs. control. Data were obtained from at least three independent
experiments.
494 K. Fujishita et al.compared, which was summarized in B. For photon count-
ing, we deﬁned a rectangle (50 mms squares) at the center
of the stimulated site, and then measured the averaged
photon intensity within the squares (see Figure 4Aa & a0
white squares), which was then converted to the absolute
ATP concentration using a standard ATP-photon-intensity
curve. Mechanical stimulation produced a signiﬁcant rise
in the extracellular ATP concentration in ATRA-treated
and control NHEKs (Figure 4B). The extracellular ATP
concentrations 60 s after stimulation in ATRA-treated and
control NHEKs were 7.30 T 1.31 (n = 17) and 5.28 T 0.94
(n = 14) mM, respectively ( P G 0.05). However, the basal
ATP concentration in ATRA-treated NHEKs was signiﬁ-
cantly lower than that in control cells (Figure 4B, 3.09 T
0.88 (n = 17) vs. 1.40 T 0.16 (n = 14) mM, P G 0.05).
Discussion
In the present study, we demonstrated that ATRA and
Am80, a synthesized agonist to RARs, selectively in-
creased the expression of P2Y2 receptors in cultured
NHEKs. P2Y2 receptors are relatively localized at the
proliferative basal layer of keratinocytes [17], and activa-
tion of P2Y2 receptors results in proliferation of the
epidermis in vivo [17] and in vitro [3]. Retinoids are
known to induce both epidermal proliferation and differ-
Figure 3. Enhancement by ATRA and Am80 of P2Y2 receptor-mediated
increase in [Ca
2+]i in NHEKs. A. Typical traces of the UTP-evoked
changes in [Ca
2+]i in NHEKs. NHEKs were incubated with 0.1 mM ATRA
(middle) or Am80 (bottom) for 6 h, incubated with normal culture medium
for another 18 h, and then the fura-2 based [Ca
2+]i measurement was
performed. UTP (100 mM) was applied to cells for 10 s and the increase in
the DF340/F380 ratio was calculated (n = 110Y125). After the initial UTP-
application, the extracellular Ca
2+ was removed (0 Ca
2+), and the second
UTP was applied to the cells in the absence of extracellular Ca
2+. Effect of
ATRA and Am80 on the UTP-evoked elevation in [Ca
2+]i in NHEKs in
the presence and absence of extracellular Ca
2+ was summarized in B.
Asterisks show signiﬁcant difference from control (without retinoids)
(*P G 0.05; **P G 0.01).
Figure 2. Time- and concentration-dependency of three different
retinoids-induced changes in mRNAs in NHEKs. Diagram shows the
quantity of P2Y2 mRNAs detected by real-time RT-PCR after treatment
with 0.001Y1 mM ATRA (A), Am80 (B) and 9-cisRA (C) for 2Y24 h. The
P2Y2 mRNA levels in cells treated with various concentrations of
retinoids were normalized by those in retinoids-untreated control cells at
each incubation period (2, 6, 12 and 24 h), and expressed as Bpercentage
(%) of control.^ All these retinoids, and especially Am80, caused a linear
increase in P2Y2 mRNAs in a concentration- and time-dependent fashion.
Asterisks show signiﬁcant difference in the P2Y2 mRNA levels from
control groups (*P G 0.05; **P G 0.01). Data were obtained from at least
three independent experiments.
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of P2Y2 receptors by retinoids may be the mechanism by
which retinoids induce the cell growth of proliferative
basal keratinocytes.
Ever since the discovery of retinoic acid, there has been
growing interest in retinoid-induced pleiotropic effects [11].
With regard to the skin, retinoids have been used clinically
for various skin disorders or problems such as psoriasis [22],
wrinkles [23], acne [24] and cancer [25Y27]. Although
retinoids can act on organs other than the epidermis and
reveal their therapeutic effects, for example, facilitation of
collagen formation in the dermis and inhibition of seba-
ceous gland activities, they directly act on the epidermis
itself and regulate both its proliferation and differentiation
[13Y15]. The epidermis expresses RARs and RXRs, es-
pecially RARg and RXRa [9]. Activation of RARs causes
keratinocytic differentiation and hyperproliferation [28]
[14]. RXRa are involved in retinoid-induced cell prolifer-
ation in adult mouse skin [29], and RARg/RXRa hetero-
dimers in suprabasal keratinocytes are required for
retinoid-induced epidermal hyperplasia [15]. In the present
study, we showed that ATRA and Am80 dramatically and
selectively increased the expression of P2Y2 receptors.
Subcutaneous injection of UTP, an agonist to P2Y2 re-
ceptors, generates epidermal hyperplasia that results from
hyperproliferation of basal keratinocytes in vivo [17]. In-
cubation of cultured keratinocytes with UTP causes epider-
mal proliferation in vitro [3]. These ﬁndings suggest that
P2Y2 receptors in basal keratinocytes may be an important
targetforretinoid-inducedproliferation,i.e.,retinoidsacting
mainly on RARs, presumably RARg, in the epidermis
upregulate the expression and function of P2Y2 receptors,
thereby leading to the proliferation of basal keratinocytes.
Xiao et al. (1999) have already shown that activation of
RARg/RXRa heterodimers in epidermis resulted in the up-
regulation of heparin-binding epidermal growth factor
(HB-EGF), by which retinoid induces the cell growth of
basal keratinocytes [14]. However, the production of HB-
EGF occurs not in basal layer but in differentiated supra-
basal cells which in turn stimulate basal keratinocytes to
proliferate in a paracrine manner. We used cultured
NHEKs and demonstrated that both ATRA and Am80
selectively upregulated P2Y2 receptor genes and their
functions. Keratinocytes cultured in vitro are considered
to be similar to basal layer keratinocytes in vivo based on
their ability to proliferate and express basal cell-speciﬁc
genes such as keratin-5 or keratin-14 [30]. P2Y2 receptors
are mainly localized in the proliferative basal layer of
keratinocytes in situ [17]. Thus, in addition to differentiated
suprabasal cells [14], retinoids seem to affect the function
of basal keratinocytes directly to cause cell growth.
NHEKs release ATP in response to mechanical stimula-
tion, and retinoids had no signiﬁcant effect on the evoked
releaseofATP(Figure4). It is therefore suggested that ATP
released from the basal cell layer and acting on P2Y2
receptors could function in an autocrine manner to control
the proliferation in basal keratinocytes. Retinoids may cause
proliferation by facilitating the ATP/P2Y2 autocrine sig-
nals. Although retinoids had no signiﬁcant effect on the
release of ATP in response to mechanical stimulation, they
reduced the basal ATP release in NHEKs (Figure 4B). This
complexity in the ATP release in NHEKs might explain the
mixed and multiple effects of retinoids.
Basal keratinocytes also express P2Y1 receptors in situ
[17]. However, the effect of the P2Y1 agonists 2methyl-
thio-ADP (2MeSADP) on epidermal proliferation in vivo is
Figure 4. Visualization of release of ATP from NHEKs. The image
panels in A show ATP-derived photons (white dots) in a ﬁeld of ATRA-
treated (right) and -untreated control NHEKs (left). NHEKs were
incubated with 0.1 mM ATRA for 6 h. Cells were bathed in lucifer-
inYluciferase reagent and the bioluminescence signals were obtained with
a VIM camera (see Materials and methods Section) with an exposure time
of 10 s. Sequential images show the ATP-derived photon-signals before
(j10 s; b & b0) and 10 (c & c0), 20 (d & d0) and 30 s (e & e0) after
mechanical stimulation. The positions of the pipettes are shown in phase-
contrast images of NHEKs (a & a0). In B, the accumulative photon
intensity in 60 s was converted to the absolute extracellular ATP con-
centration using a standard ATP-photon intensity relationship curve
determined with an ATP standard solution (control, n = 17; ATRA-
treated, n = 14). Photons within 50 mms squares around the stimulated site
(shown as white squares in a & a0 panels in A) were calculated. Asterisks
show signiﬁcant difference from basal groups (**P G 0.01) and dagger
shows signiﬁcant difference from control basal groups (.P G 0.05).
496 K. Fujishita et al.much weaker than that of UTP, suggesting that P2Y2
receptors have a more signiﬁcant role in the proliferation
[17]. P2Y1 and P2Y2 receptors share Gq/11-coupled
intracellular signal cascades. Activation of both receptor
results in inositol 1,4,5-trisphosphate (InsP3) production,
leading to Ca
2+ mobilization from the store [31Y33]. In
addition, activation of both receptors also induces ERK1/2
MAPkinase cascades in some cells such as astrocytes [34,
35]. However, P2Y2 receptors seem to be much more
closely related to proliferation of the epidermis. This
discrepancy may be explained by the lower expression
level of P2Y1 receptors in basal keratinocytes. In fact, the
P2Y1 receptor agonist 2meSADP caused only a slight
increase in [Ca
2+]i in cultured NHEKs [16], though
quantitative analysis of the expression levels and localiza-
tion of both receptors in situ are required to clarify this
issue. In any case, retinoids upregulated the P2Y2 receptor
but not P2Y1 receptor expression in NHEKs (Table 1 and
Figure 1). The published sequence of the human P2Y2
receptor gene promoter shows that the P2Y2 receptor has
putative RAREs in the upstream promoter region (data not
shown), which may also support that P2Y2 receptors are a
likely target gene for retinoids.
In summary, we demonstrated that retinoids upregulate
P2Y2 receptors via mainly RAR in NEHKs. Judging from
the well-known ﬁnding that activation of P2Y2 receptors
regulates the proliferation of the epidermis, retinoids may
exert their therapeutic effects through the upregulation of
P2Y2 receptors in the skin.
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